2025
The Effectivity and Safety of Naltrexone/Bupropion in Patients Suffering from Overweight and Obesity in a Real-World Setting.
Jense MTF, Knibbeler L, Hoogma RPLM, Palm-Meinders IH, Greve JWM, Boerma EG.
Obes Facts. 2025 Apr 21:1-8. (article)

2024
Impact of a Health Coach-Led, Text-Based Digital Behavior Change Intervention on Weight Loss and Psychological Well-Being in Patients Receiving a Procedureless Intragastric Balloon Program: Prospective Single-Arm Study.
Sacher PM, Fulton E, Rogers V, Wilson J, Gramatica M, Dent JE, Aarts EO, Eccleston D, Greve JW, Palm-Meinders I, Chuttani R.
JMIR Form Res. 2024 Jul 31;8:e54723. (article)

Liraglutide (Saxenda) Combined with Lifestyle Coaching for Weight Loss in a Bariatric Center. Palm-Meinders IH, Jense MTF, Greve JWM, Boerma EJG.
J Surgery. 2024; 4(1): 1157. (article)

2023
The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short‑Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity.
Marijn T.F. Jense, Inge H. Palm‑Meinders, Boy Sanders, Evert‑Jan G. Boerma, Jan Willem M. Greve.
Obesity surgery (2023). (article)